N-methyl-N-[3]pyridyl-acetamide | 55899-01-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: N-methyl-N-[3]pyridyl-acetamide
• 英文别名: N-Methyl-N-[3]pyridyl-acetamid；N-methyl-N-3-pyridinyl-acetamide；N-methyl-N-(pyridin-3-yl)acetamide；N-methyl-N-pyridin-3-ylacetamide
• CAS: 55899-01-9
• 化学式: C₈H₁₀N₂O
• mdl: MFCD01566849
• 分子量: 150.18
• InChiKey: DIBVGDONZMMHTK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  33.2
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N-methyl-N-[3]pyridyl-acetamide 在 双氧水 作用下， 生成 3-(Acetyl-methyl-amino)-pyridin-1-oxid
  参考文献：
  名称：

  Kalatzis, Evangelos; Papadopoulos, Panayiotis, Journal of the Chemical Society. Perkin transactions II, 1981, p. 248 - 255

  摘要：

  DOI：
• 作为产物：
  描述：

  3-溴吡啶 在 copper(II) sulfate 作用下， 生成 N-methyl-N-[3]pyridyl-acetamide
  参考文献：
  名称：

  Plazek et al., Roczniki Chemii, 1935, vol. 15, p. 365,370

  摘要：

  DOI：

文献信息

• Acceleration of Pd-Catalyzed Amide N-Arylations Using Cocatalytic Metal Triflates: Substrate Scope and Mechanistic Study
  作者：Joseph Becica、Graham E. Dobereiner

  DOI：10.1021/acscatal.7b01317

  日期：2017.9.1

  comparison with iodobenzene (PhI). The observation of an aryl halide dependence on rate and various qualitative kinetic experiments are consistent with a mechanism in which ligand exchange of halide for amide (“transmetalation”) is turnover limiting. The mechanism may be different depending on whether PhBr or PhI is used as a coupling partner. Oxidative addition complexes (xantphos)Pd(Ph)(X) (X = Br, I;

  助催化三氟甲磺酸金属盐助剂加速了酰胺与芳基卤化物的钯/黄磷催化的交叉偶联。一项对氮亲核试剂的调查显示，当Al（OTf）3时，各种N-芳基酰胺产品的收率都有所提高除了某些例外，它被用作催化添加剂。初始催化速率表明，与溴代碘苯（PhI）相比，使用溴代苯（PhBr）时路易斯酸的加速作用更为明显。芳基卤化物对速率的依赖性以及各种定性动力学实验的观察结果与卤化物配体交换为酰胺（“过渡金属化”）受到限制的机理是一致的。该机制可能会有所不同，具体取决于将PhBr或PhI用作偶联伴侣。制备了氧化加成络合物（xantphos）Pd（Ph）（X）（X = Br，I; xantphos = 4,5-双（二苯基膦基）-9,9-二甲基x吨），可能是催化的中间体; 与Yb（OTf）3的不同相互作用 在溶液中类似于催化机理的卤化物依赖性，我们提出该机理源自催化过程中可逆的路易斯酸介导的卤化物抽象。
• METHODS FOR INHIBITING DRUG DEGRADATION
  申请人：SEQUOIA PHARMACEUTICALS, INC.

  公开号：US20150284352A1

  公开（公告）日：2015-10-08

  Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450. Pharmaceutical compositions are provided that can act as boosters to improve the pharmacokinetics, enhance the bioavailability, and enhance the therapeutic effect of drugs that undergo in vivo degradation by cytochrome P450 enzymes.

  提供了一种抑制细胞色素P450酶的方法，可用于改善疾病治疗，防止药物或其他分子被细胞色素P450降解。提供了可以充当增强剂的药物组合物，以改善药物的药代动力学，增加生物利用度，并增强那些在体内被细胞色素P450酶降解的药物的治疗效果。
• Substituted Tetrahydropyrrolopyrazine Compounds and the Use Thereof in the Treatment and/or Inhibition of Pain
  申请人：Merla Beatrix

  公开号：US20080167315A1

  公开（公告）日：2008-07-10

  Substituted tetrahydropyrrolopyrazine compounds corresponding to the formula I: processes for their preparation, pharmaceutical compositions comprising these compounds and the use of these compounds for the treatment and/or inhibition of pain and other disorders or disease states at least partly mediated by KCNQ2/3 K + channels.

  与公式I对应的替代四氢吡咯吡嗪化合物： 它们的制备方法，包含这些化合物的药物组合物以及利用这些化合物治疗和/或抑制至少部分由KCNQ2/3 K + 通道介导的疼痛和其他疾病或疾病状态的方法。
• SUBSTITUTED TETRAHYDROPYRROLOPYRAZINE COMPOUNDS AND THE USE THEREOF IN THE TREATMENT AND/OR INHIBITION OF PAIN
  申请人：MERLA Beatrix

  公开号：US20100004252A1

  公开（公告）日：2010-01-07

  Substituted tetrahydropyrrolopyrazine compounds corresponding to the formula I: processes for their preparation, pharmaceutical compositions comprising these compounds and the use of these compounds for the treatment and/or inhibition of pain and other disorders or disease states at least partly mediated by KCNQ2/3 K + channels.

  公式I对应的替代四氢吡咯吡嗪化合物：其制备过程，包含这些化合物的制药组合物以及这些化合物用于治疗和/或抑制至少部分由KCNQ2 / 3 K +通道介导的疼痛和其他疾病或疾病状态的用途。
• Polyene macrolide derivatives
  申请人：S P A SOCIETA' PRODOTTI ANTIBIOTICI S.p.a.

  公开号：EP0434943A1

  公开（公告）日：1991-07-03

  There has been prepared a series of secondary and tertiary amide derivatives of the polyene antibiotic partricin as well as of its single components, partricin A and B, having radicals on the amide nitrogen, said radicals being preferab­ly substituted, in turn, with various amine groups. The syn­thesis has been carried out by reacting the C-18 carboxyl of the polyene with suitable amines, in the presence of diphenyl phosphorazidate as activator. From said amines, especially those substituted with basic groups, many salts with a good water solubility have been prepared by reacting them with pharmacologically compatible acids. It has been shown that many amines and related salts are more active than, or as active as, the starting product as antimycotic and antiprotozoan agents, while being less toxic and less hemolytic, and can therefore find a useful applica­tion in the clinical and veterinary therapy. The compounds can also be used in the treatment of hypercholesteremia and hyperlipemia conditions and of some steroid hormones unbalan­ces, as well as in the pharmacological therapy of hyper­trophic prostate, and in the treatment of lipid envelope virus infections.

  现已制备出一系列聚烯类抗生素部分霉素及其单一成分部分霉素 A 和 B 的仲酰胺和叔酰胺衍生物，这些衍生物的酰胺氮上具有基团，所述基团最好依次被各种胺基团取代。合成的方法是：在作为活化剂的磷酸二苯酯存在下，将聚烯的 C-18 羧基与合适的胺反应。 上述胺类，特别是那些被碱性基团取代的胺类，通过与药理学上相容的酸反应，制备出了许多水溶性良好的盐类。 研究表明，许多胺和相关盐类作为抗霉菌剂和抗原虫剂的活性高于或等同于起始产物，同时毒性和溶血性较低，因此可以在临床和兽医治疗中得到有用的应用。这些化合物还可用于治疗高胆固醇血症、高血脂症和某些类固醇激素失衡，以及肥大性前列腺的药物治疗和脂质包膜病毒感染的治疗。